Synopsis
Synopsis
0
USDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine
2. Bactil
3. Busidril
4. Ebastel
5. Evastel
6. Kestin
7. Kestine
8. Las W-090
1. 90729-43-4
2. Kestine
3. Ebastel
4. Ebastin
5. Kestin
6. Bactil
7. Las W-090
8. Rp 64305
9. 4-(4-benzhydryloxypiperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one
10. Las-w-090
11. 1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one
12. Las-w 090;rp64305
13. Rp-64305
14. Chembl305660
15. Tqd7q784p1
16. 4-(4-(benzhydryloxy)piperidin-1-yl)-1-(4-(tert-butyl)phenyl)butan-1-one
17. Rp64305
18. Ncgc00164603-01
19. Evastel
20. Dsstox_cid_26472
21. Dsstox_rid_81644
22. Dsstox_gsid_46472
23. Ebastinum [latin]
24. Ebastina [spanish]
25. Ebastina
26. Ebastinum
27. Estivan
28. Bastel
29. Cas-90729-43-4
30. Unii-tqd7q784p1
31. Ebastine [usan:inn:ban]
32. 4-(4-(benzhydryloxy)piperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one
33. 4-[4-(benzhydryloxy)piperidin-1-yl]-1-(4-tert-butylphenyl)butan-1-one
34. 4-diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine
35. Las-w 090
36. No-sedat
37. Kestine (tn)
38. Mfcd00865661
39. 4'-tert-butyl-4-(4-(diphenylmethoxy)piperidino)butyrophenone
40. Ebastine [usan]
41. Ebastine [inn]
42. Ebastine [jan]
43. Ebastine [mi]
44. 4-(4-benzhydryloxy-1-piperidyl)-1-(4-tert-butylphenyl)butan-1-one
45. Ebastine [mart.]
46. Ebastine [who-dd]
47. 1-(4-(1,1-dimethylethyl)phenyl)-4-(4-(diphenylmethoxy)-1-piperidinyl)-1-butanone
48. Schembl18467
49. Ebastine [ep Impurity]
50. Ebastine (jp17/usan/inn)
51. Ebastine [ep Monograph]
52. Dtxsid6046472
53. Bdbm22873
54. Chebi:31528
55. Hms3261i03
56. Hms3887c19
57. Bcp08300
58. Hy-b0674
59. Zinc3781952
60. Tox21_112225
61. Tox21_500361
62. Bbl029069
63. Ebastine, >=98% (hplc), Solid
64. S4262
65. Stk624411
66. Akos005557491
67. Tox21_112225_1
68. Ccg-221665
69. Db11742
70. Ks-1349
71. Lp00361
72. Sdccgsbi-0633701.p001
73. 1-butanone, 1-(4-(1,1-dimethylethyl)phenyl)-4-(4-(diphenylmethoxy)-1-piperidinyl)-
74. Ncgc00164603-02
75. Ncgc00164603-04
76. Ncgc00164603-05
77. Ncgc00164603-11
78. Ncgc00261046-01
79. Ac-15213
80. Ac-30629
81. Be164400
82. Db-057220
83. E0925
84. Ft-0630975
85. W-090
86. A14946
87. C77079
88. D01478
89. Ab01325291-02
90. 729e434
91. A843625
92. Sr-01000883997
93. Q-201053
94. Q2327739
95. Sr-01000883997-1
96. 4-diphenylmethoxy-1[3-(4-tert-butylbenzoyl)propyl]-piperidine
97. Ebastine, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 469.7 g/mol |
---|---|
Molecular Formula | C32H39NO2 |
XLogP3 | 7.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 10 |
Exact Mass | 469.298079487 g/mol |
Monoisotopic Mass | 469.298079487 g/mol |
Topological Polar Surface Area | 29.5 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 594 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
R06AX22
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
R - Respiratory system
R06 - Antihistamines for systemic use
R06A - Antihistamines for systemic use
R06AX - Other antihistamines for systemic use
R06AX22 - Ebastine
Ebastine has known human metabolites that include 4-(4-tert-butylphenyl)-4-oxobutanal and Deslakylebastine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Certificate Number : CEP 2013-051 - Rev 02
Issue Date : 2024-04-22
Type : Chemical
Substance Number : 2015
Status : Valid
Registration Number : 227MF10209
Registrant's Address : 5th Floor, Lakshminarayan Complex, 10/1, Palace Road, Bangalore-560052, India
Initial Date of Registration : 2015-08-11
Latest Date of Registration : --
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0156
Address of the Firm :
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2019-02-15
Registration Number : 20120824-156-I-42-01(1)
Manufacturer Name : Bal Pharma Limited
Manufacturer Address : 61-B, Bommasandra Industrial Area Bangalore – 560 099
Registration Number : 218MF10791
Registrant's Address : 5th Floor, Lakshminarayan Complex, 10/1, Palace Road, Bangalore-560052, India
Initial Date of Registration : 2006-10-06
Latest Date of Registration : --
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2019-02-15
Registration Number : 20120824-156-I-42-01(1)
Manufacturer Name : Bal Pharma Limited
Manufacturer Address : 61-B, Bommasandra Industrial Area Bangalore – 560 099
Certificate Number : R0-CEP 2020-139 - Rev 00
Issue Date : 2021-09-28
Type : Chemical
Substance Number : 2015
Status : Valid
Certificate Number : R1-CEP 2009-106 - Rev 03
Issue Date : 2023-07-13
Type : Chemical
Substance Number : 2015
Status : Valid
Date of Issue : 2019-08-16
Valid Till : 2022-08-15
Written Confirmation Number : WC-0225
Address of the Firm :
Certificate Number : R1-CEP 2015-104 - Rev 01
Issue Date : 2022-08-22
Type : Chemical
Substance Number : 2015
Status : Valid
Registration Number : 221MF10107
Registrant's Address : General Miter, 151, 08022 Barcelona, Spain
Initial Date of Registration : 2009-06-02
Latest Date of Registration : --
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2013-08-21
Registration Number : 20130821-156-I-323-05
Manufacturer Name : Almirall Farmaceuticas Industries, SA@Ranke Quimica, SA_x000D_ (Micronized Ebastin Manufacturing Plant)
Manufacturer Address : Ctra. de Martorell 41-61 08740 Sant Andreu de la Barca (Barcelona), Spain@Ctra. C-35, Km 58.85, Sant Celoni 08470 Barcelona, Spain
Certificate Number : R1-CEP 2017-287 - Rev 00
Issue Date : 2023-04-05
Type : Chemical
Substance Number : 2015
Status : Valid
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2013-08-21
Registration Number : 20130821-156-I-323-05
Manufacturer Name : Almirall Farmaceuticas Industries, SA@Ranke Quimica, SA_x000D_ (Micronized Ebastin Manufacturing Plant)
Manufacturer Address : Ctra. de Martorell 41-61 08740 Sant Andreu de la Barca (Barcelona), Spain@Ctra. C-35, Km 58.85, Sant Celoni 08470 Barcelona, Spain
Certificate Number : CEP 2013-243 - Rev 03
Issue Date : 2024-09-25
Type : Chemical
Substance Number : 2015
Status : Valid
Date of Issue : 2022-06-14
Valid Till : 2025-07-04
Written Confirmation Number : WC-0070
Address of the Firm :
Certificate Number : CEP 2017-058 - Rev 01
Issue Date : 2024-06-28
Type : Chemical
Substance Number : 2015
Status : Valid
Date of Issue : 2019-07-22
Valid Till : 2022-07-22
Written Confirmation Number : WC-0139
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?